Citadel Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.5M Sell
5,624,682
-1,867,347
-25% -$15.1M 0.01% 558
2025
Q1
$62.8M Sell
7,492,029
-1,488,939
-17% -$12.5M 0.01% 398
2024
Q4
$71.1M Buy
8,980,968
+88,675
+1% +$702K 0.01% 386
2024
Q3
$74M Sell
8,892,293
-1,096,432
-11% -$9.12M 0.01% 342
2024
Q2
$63.4M Buy
9,988,725
+4,921,242
+97% +$31.2M 0.01% 394
2024
Q1
$30.7M Sell
5,067,483
-1,429,607
-22% -$8.66M 0.01% 683
2023
Q4
$39.4M Buy
6,497,090
+3,808,360
+142% +$23.1M 0.01% 556
2023
Q3
$11.3M Buy
2,688,730
+1,493,222
+125% +$6.3M ﹤0.01% 1088
2023
Q2
$3.71M Buy
1,195,508
+160,305
+15% +$497K ﹤0.01% 1924
2023
Q1
$1.44M Buy
1,035,203
+345,449
+50% +$480K ﹤0.01% 2831
2022
Q4
$1.37M Sell
689,754
-956,839
-58% -$1.9M ﹤0.01% 2922
2022
Q3
$3.33M Buy
1,646,593
+212,703
+15% +$430K ﹤0.01% 2242
2022
Q2
$4.56M Sell
1,433,890
-31,230
-2% -$99.3K ﹤0.01% 1949
2022
Q1
$6.11M Sell
1,465,120
-130,827
-8% -$546K ﹤0.01% 1886
2021
Q4
$7.65M Buy
1,595,947
+435,040
+37% +$2.08M ﹤0.01% 1718
2021
Q3
$6.2M Buy
1,160,907
+534,969
+85% +$2.86M ﹤0.01% 1866
2021
Q2
$3.21M Buy
625,938
+5,423
+0.9% +$27.8K ﹤0.01% 2667
2021
Q1
$4.18M Sell
620,515
-859,409
-58% -$5.78M ﹤0.01% 2315
2020
Q4
$6.76M Buy
1,479,924
+172,597
+13% +$789K ﹤0.01% 1522
2020
Q3
$5.07M Buy
1,307,327
+717,014
+121% +$2.78M ﹤0.01% 1507
2020
Q2
$2.81M Buy
590,313
+238,737
+68% +$1.14M ﹤0.01% 1946
2020
Q1
$1.22M Sell
351,576
-87,734
-20% -$305K ﹤0.01% 2668
2019
Q4
$2.12M Sell
439,310
-210,945
-32% -$1.02M ﹤0.01% 2312
2019
Q3
$1.89M Buy
650,255
+73,904
+13% +$214K ﹤0.01% 2416
2019
Q2
$4.13M Buy
+576,351
New +$4.13M ﹤0.01% 1807
2019
Q1
Hold
0
4494
2018
Q4
Hold
0
4470
2018
Q3
Sell
-604,634
Closed -$9.92M 4248
2018
Q2
$9.92M Buy
+604,634
New +$9.92M ﹤0.01% 1015